Powles, ThomasKockx, MarkRodriguez-Vida, AlejoDuran, IgnacioCrabb, Simon JVan Der Heijden, Michiel SSzabados, BernadettPous, Albert FontGravis, GwenaelleHerranz, Urbano AnidoProtheroe, AndrewRavaud, AlainMaillet, DenisMendez, Maria JoseSuarez, CristinaLinch, MarkPrendergast, Aaronvan Dam, Pieter-JanStanoeva, DianaDaelemans, SofieMariathasan, SanjeevTea, Joy SMousa, KellyBanchereau, RomainCastellano, Daniel2025-01-072025-01-072020https://hdl.handle.net/10668/25386An amendment to this paper has been published and can be accessed via a link at the top of the paper.enPublisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.research article32555515open access10.1038/s41591-020-0923-31546-170Xhttps://www.nature.com/articles/s41591-020-0923-3.pdf